ArticlePharmaceuticals (Basel, Switzerland)2021

UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling.

Carmine Giorgio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.